Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
7.10
+0.34 (5.03%)
At close: Aug 25, 2026, 4:00 PM EDT
7.09
-0.01 (-0.14%)
After-hours: Aug 25, 2026, 7:59 PM EDT

Nuvation Bio Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Buy" and an average price target of $13.1. The average 1-year stock price forecast is 84.51% higher than the current stock price, while the lowest is $7.00 (-1.41%) and the highest is $21 (+195.77%).

Price Target: $13.1 (+84.51%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$7.00$13.1$12.5$21
Change-1.41%+84.51%+76.06%+195.77%

Analyst Ratings

The average analyst rating for Nuvation Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy777776
Buy222223
Hold111111
Sell000000
Strong Sell000000
Total101010101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
n/a
BuyInitiatesn/an/aAug 21, 2026
J.P. Morgan
J.P. Morgan
Buy
Initiates
$13
BuyInitiates$13+83.10%Aug 18, 2026
B. Riley Securities
B. Riley Securities
Buy
Maintains
$12$14
BuyMaintains$12$14+97.18%Aug 7, 2026
Truist Financial
Truist Financial
Buy
Maintains
$13
BuyMaintains$13+83.10%Aug 7, 2026
RBC Capital
RBC Capital
Buy
Reiterates
$19$20
BuyReiterates$19$20+181.69%Aug 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
199.12M
from 62.90M
Increased by 216.56%
Revenue Next Year
282.43M
from 199.12M
Increased by 41.83%
EPS This Year
-0.29
from -0.49
EPS Next Year
-0.02
from -0.29
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
---7.87M62.90M199.12M
Revenue Growth
----698.96%216.56%
Gross Profit
---795.00K53.60M175.24M
Gross Margin
---10.10%85.22%88.00%
Operating Income
-89.53M-119.73M-99.82M-167.56M-213.06M-127.96M
Net Income
-86.85M-104.20M-75.80M-567.94M-204.63M-132.97M
EPS
-----0.49-0.29
Free Cash Flow
-39.03M-62.44M-41.59M-52.19M-115.78M-87.17M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High220.8M
Avg199.1M
Low176.2M

Revenue Growth

Revenue Growth202620272028
High
251.0%
Avg
216.6%
Low
180.1%

EPS Forecast

EPS202620272028
High-0.29
Avg-0.29
Low-0.29

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-